Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Abstract
Muscarinic acetylcholine receptors (mAChRs), M(1)-M(5), regulate the activity of numerous fundamental central and peripheral functions. The lack of small-molecule ligands that can block or activate specific mAChR subtypes with high selectivity has remained a major obstacle in defining the roles of the individual receptor subtypes and in the development of novel muscarinic drugs. Recently, phenotypic analysis of mutant mouse strains deficient in each of the five mAChR subtypes has led to a wealth of new information regarding the physiological roles of the individual receptor subtypes. Importantly, these studies have identified specific mAChR-regulated pathways as potentially novel targets for the treatment of various important disorders including Alzheimer's disease, schizophrenia, pain, obesity and diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Gq/11-coupled M1, M3 and M5 mAChRs elicit Ca2+ release from the endoplasmic reticulum (ER) by activating the downstream phospholipase C/inositol 1,4,5-trisphosphate/inositol 1,4,5-trisphosphate receptor (PLC/IP3/IP3R) cascade49, the same pathway triggered by TCR signaling.”
From Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma (2023) · cites this paper as [49]
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
The role of acetylcholine in learning and memory
Hasselmo, M. E. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.09.002 · Cited by 1,693 · cited 1×
“Alzheimer's disease and cognitive impairments A convincing body of data indicate that mAChRs have central roles in facilitating cognitive function”
BackgroundInternational Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
Caulfield, M. P., & Birdsall, N. J. M. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01362-0 · Cited by 1,474
Muscarinic Receptors—Characterization, coupling and function
Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
The current status of the dopamine hypothesis of schizophrenia
CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958
Autonomic regulation of islet hormone secretion - Implications for health and disease
Ahrén, B. (2000) · Diabetologia · doi:10.1007/s001250051322 · Cited by 909
Cited by
Targeting bile‐acid signalling for metabolic diseases
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422
Tracey, K. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2566 · Cited by 1,154
The effect of pain on cognitive function: A review of clinical and preclinical research
Moriarty, O., McGuire, B. E., & Finn, D. P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.002 · Cited by 1,122
“Muscarinic receptor agonists, such as vendacycline, oxotremorine, CMI-936 and CMI-1145, have also shown potent analgesic action (Tata, 2008; Wess et al., 2007).”
BackgroundAllosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Self-citationStructure and dynamics of the M3 muscarinic acetylcholine receptor
Kruse, A. C., Hu, J., Pan, A. C., Arlow, D. H., Rosenbaum, D. M., Rosemond, E., Green, H. F., Liu, T., Chae, P. S., Dror, R. O., et al. (2012) · Nature · doi:10.1038/nature10867 · Cited by 811
Self-citationStructure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Haga, K., Kruse, A. C., Asada, H., Yurugi-Kobayashi, T., Shiroishi, M., Zhang, C., Weis, W. I., Okada, T., Kobilka, B. K., Haga, T., et al. (2012) · Nature · doi:10.1038/nature10753 · Cited by 792
Bile acids as regulatory molecules
Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., & Dent, P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900007-jlr200 · Cited by 694
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
Pols, T. W. H., Noriega, L. G., Nomura, M., Auwerx, J., & Schoonjans, K. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.004 · Cited by 454
Muscarinic acetylcholine receptors: novel opportunities for drug development
Kruse, A. C., Kobilka, B. K., Gautam, D., Sexton, P. M., Christopoulos, A., & Wess, J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4295 · Cited by 437
Self-citationIslet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Ahrén, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2782 · Cited by 419
A genetically encoded fluorescent acetylcholine indicator for in vitro and in vivo studies
Jing, M., Zhang, P., Wang, G., Feng, J., Mesik, L., Zeng, J., Jiang, H., Wang, S., Looby, J. C., Guagliardo, N. A., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4184 · Cited by 387
van den Buuse, M. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp132 · Cited by 346
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
Thal, D. M., Sun, B., Feng, D., Nawaratne, V., Leach, K., Felder, C. C., Bures, M. G., Evans, D. A., Weis, W. I., Bachhawat, P., et al. (2016) · Nature · doi:10.1038/nature17188 · Cited by 335
The role of G protein-coupled receptors in the pathology of Alzheimer's disease
Thathiah, A., & De Strooper, B. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2977 · Cited by 288
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
Conn, P. J., Jones, C. K., & Lindsley, C. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.002 · Cited by 286
The NMDA Receptor and Schizophrenia
Balu, D. T. (2016) · Advances in Pharmacology · doi:10.1016/bs.apha.2016.01.006 · Cited by 285
PtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identity
Nakatsu, F., Baskin, J. M., Chung, J., Tanner, L. B., Shui, G., Lee, S. Y., Pirruccello, M., Hao, M., Ingolia, N. T., Wenk, M. R., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201206095 · Cited by 277
Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon
Knoop, K. A., McDonald, K. G., McCrate, S., McDole, J. R., & Newberry, R. D. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.58 · Cited by 275
Masuho, I., Ostrovskaya, O., Kramer, G. M., Jones, C. D., Xie, K., & Martemyanov, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.aab4068 · Cited by 265
Shirey, J. K., Brady, A. E., Jones, P. J., Davis, A. A., Bridges, T. M., Kennedy, J. P., Jadhav, S. B., Menon, U. N., Xiang, Z., Watson, M. L., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3930-09.2009 · Cited by 237
Gómez-Ramos, A., Díaz-Hernández, M., Rubio, A., Miras-Portugal, M. T., & Avila, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.12.010 · Cited by 232
Jones, C. K., Byun, N., & Bubser, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.199 · Cited by 225
Threlfell, S., Clements, M. A., Khodai, T., Pienaar, I. S., Exley, R., Wess, J., & Cragg, S. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5620-09.2010 · Cited by 224
Self-citationMartella, G., Tassone, A., Sciamanna, G., Platania, P., Cuomo, D., Viscomi, M. T., Bonsi, P., Cacci, E., Biagioni, S., Usiello, A., et al. (2009) · Brain · doi:10.1093/brain/awp194 · Cited by 217
The epithelial cholinergic system of the airways
Kummer, W., Lips, K. S., & Pfeil, U. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0455-2 · Cited by 200
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Aringhieri, S., Carli, M., Kolachalam, S., Verdesca, V., Cini, E., Rossi, M., McCormick, P. J., Corsini, G. U., Maggio, R., & Scarselli, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.06.012 · Cited by 199
The crosstalk between autonomic nervous system and blood vessels.
Sheng, Y., & Zhu, L. (2018) · PubMed · Cited by 281
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs in Vitro and in Vivo
Thompson, K. J., Khajehali, E., Bradley, S. J., Navarrete, J. S., Huang, X. P., Slocum, S., Jin, J., Liu, J., Xiong, Y., Olsen, R. H. J., et al. (2018) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00012 · Cited by 193
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Howes, O. D., Bukala, B. R., & Beck, K. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-023-00904-0 · Cited by 192
Hulse, E. J., Davies, J. O. J., Simpson, A. J., Sciuto, A. M., & Eddleston, M. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1150ci · Cited by 189
Schechtmann, G., Song, Z., Ultenius, C., Meyerson, B. A., & Linderoth, B. (2008) · Pain · doi:10.1016/j.pain.2008.03.023 · Cited by 187
Leach, K., Loiacono, R. E., Felder, C. C., McKinzie, D. L., Mogg, A., Shaw, D. B., Sexton, P. M., & Christopoulos, A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.194 · Cited by 167
The chemistry and biological activity of heterocycle-fused quinolinone derivatives: A review
Shiro, T., Fukaya, T., & Tobe, M. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.004 · Cited by 166
Jeon, J., Dencker, D., Wörtwein, G., Woldbye, D. P. D., Cui, Y., Davis, A. A., Levey, A. I., Schütz, G., Sager, T. N., Mørk, A., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3843-09.2010 · Cited by 166
Self-citationGregory, K. J., Hall, N. E., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094011 · Cited by 159
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
Wold, E. A., Chen, J., Cunningham, K. A., & Zhou, J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00875 · Cited by 154
Fisher, A. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.002 · Cited by 174
Bile Acids Regulate Cardiovascular Function
Khurana, S., Raufman, J., & Pallone, T. L. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00272.x · Cited by 151
Poulin, B., Butcher, A., McWilliams, P., Bourgognon, J.-M., Pawlak, R., Kong, K. C., Bottrill, A., Mistry, S., Wess, J., Rosethorne, E. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914801107 · Cited by 151
Self-citationMuscarinic modulation of striatal function and circuitry
Goldberg, J. A., Ding, J. B., & Surmeier, D. J. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-23274-9_10 · Cited by 150
Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity
Antony, J., Kellershohn, K., Mohr‐Andrä, M., Kebig, A., Prilla, S., Muth, M., Heller, E., Disingrini, T., Dallanoce, C., Bertoni, S., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-114751 · Cited by 179
Basal forebrain cholinergic signalling: development, connectivity and roles in cognition
Ananth, M. R., Rajebhosale, P., Kim, R., Talmage, D. A., & Role, L. W. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00677-x · Cited by 148
M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Jiang, S., Li, Y., Zhang, C., Zhao, Y., Bu, G., Xu, H., & Zhang, Y. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1406-z · Cited by 171
Marlo, J. E., Niswender, C. M., Days, E., Bridges, T. M., Xiang, Y., Rodriguez, A. L., Shirey-Rice, J. K., Brady, A. E., Nalywajko, T., Luo, Q., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052886 · Cited by 159
Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia
Paul, S. M., Yohn, S. E., Popiolek, M., Miller, A., & Felder, C. C. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21101083 · Cited by 165
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug–Target Interactions
Lu, S., & Zhang, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01844 · Cited by 154
Fisher, A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07507.x · Cited by 140
Lebois, E. P., Thorn, C. A., Edgerton, J. R., Popiolek, M., & Xi, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.018 · Cited by 158
Goldberg, J. A., & Reynolds, J. N. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.067 · Cited by 163
Casarosa, P., Bouyssou, T., Germeyer, S., Schnapp, A., Gantner, F., & Pieper, M. P. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.152470 · Cited by 140
Moran, S. P., Maksymetz, J., & Conn, P. J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.10.007 · Cited by 133
Sheffler, D. J., Williams, R. D., Bridges, T. M., Xiang, Z., Kane, A. S., Byun, N. E., Jadhav, S. B., Mock, M. M., Zheng, F., Lewis, L. M., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056531 · Cited by 143
Regulation of cholinergic activity by the vesicular acetylcholine transporter
Prado, V. F., Roy, A., Kolisnyk, B., Gros, R., & Prado, M. A. M. (2013) · Biochemical Journal · doi:10.1042/bj20121662 · Cited by 151
The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling
Bock, A., Merten, N., Schrage, R., Dallanoce, C., Bätz, J., Klöckner, J., Schmitz, J., Matera, C., Simon, K., Kebig, A., et al. (2012) · Nature Communications · doi:10.1038/ncomms2028 · Cited by 132
Valant, C., Felder, C. C., Sexton, P. M., & Christopoulos, A. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074872 · Cited by 132
Molecular, Cellular and Circuit Basis of Cholinergic Modulation of Pain
Naser, P. V., & Kuner, R. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.049 · Cited by 151
Molecular properties of muscarinic acetylcholine receptors
Haga, T. (2013) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.89.226 · Cited by 164
Gavaldà, A., Miralpeix, M., Ramos, I., Otal, R., Carreño, C., Viñals, M., Domènech, T., Carcasona, C., Reyes, B., Vilella, D., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.151639 · Cited by 129
Distribution and function of the muscarinic receptor subtypes in the cardiovascular system
Saternos, H. C., Almarghalani, D. A., Gibson, H., Meqdad, M. A., Antypas, R. B., Lingireddy, A., & AbouAlaiwi, W. A. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00062.2017 · Cited by 153
Shi, Y., Oury, F., Yadav, V. K., Wess, J., Liu, X. S., Guo, X. E., Murshed, M., & Karsenty, G. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.01.005 · Cited by 126
Self-citationDrug targets for cognitive enhancement in neuropsychiatric disorders.
Wallace, T. L., Ballard, T. M., Pouzet, B., Riedel, W. J., & Wettstein, J. G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.022 · Cited by 127
Ztaou, S., Maurice, N., Camon, J., Guiraudie-Capraz, G., Goff, L. K., Beurrier, C., Liberge, M., & Amalric, M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0873-16.2016 · Cited by 141
Kolisnyk, B., Guzman, M. S., Raulic, S., Fan, J., Magalhaes, A. C., Feng, G., Gros, R., Prado, V. F., & Prado, M. A. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0395-13.2013 · Cited by 124
Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease–Like Pathology and Cognitive Decline
Medeiros, R., Kitazawa, M., Caccamo, A., Baglietto‐Vargas, D., Estrada-Hernandez, T., Cribbs, D. H., Fisher, A., & LaFerla, F. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.04.041 · Cited by 128
Candidate Neural Substrates for Off-Edge Motion Detection in Drosophila
Shinomiya, K., Karuppudurai, T., Lin, T.-Y., Lu, Z., Lee, C.-H., & Meinertzhagen, I. A. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.051 · Cited by 119
Rational design of dualsteric GPCR ligands: quests and promise
Mohr, K., Tränkle, C., Kostenis, E., Barocelli, E., De Amici, M., & Holzgrabe, U. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00601.x · Cited by 117
Overview of Muscarinic Receptor Subtypes
Eglen, R. M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-23274-9_1 · Cited by 136
Self-citationMuscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic
Yohn, S. E., Weiden, P. J., Felder, C. C., & Stahl, S. M. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.09.006 · Cited by 118
Nawaratne, V., Leach, K., Suratman, N., Loiacono, R. E., Felder, C. C., Armbruster, B. N., Roth, B. L., Sexton, P. M., & Christopoulos, A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049353 · Cited by 126
G Protein-Coupled Receptors (GPCRs) in Alzheimer’s Disease: A Focus on BACE1 Related GPCRs
Zhao, J., Deng, Y., Jiang, Z., & Qing, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00058 · Cited by 107
Bridges, T. M., Marlo, J. E., Niswender, C. M., Jones, C. K., Jadhav, S. B., Gentry, P. R., Plumley, H. C., Weaver, C. D., Conn, P. J., & Lindsley, C. W. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900286j · Cited by 107
Teng, R., Gavrilova, O., Suzuki, N., Chanturiya, T., Schimel, D. M., Hugendubler, L., Mammen, S., Yver, D. R., Cushman, S. W., Mueller, E., et al. (2011) · Nature Communications · doi:10.1038/ncomms1526 · Cited by 114
Physiological Role of Bile Acids Modified by the Gut Microbiome
Kiriyama, Y., & Nochi, H. (2021) · Microorganisms · doi:10.3390/microorganisms10010068 · Cited by 112
Kong, K. C., Butcher, A. J., McWilliams, P., Jones, D., Wess, J., Hamdan, F. F., Werry, T., Rosethorne, E. M., Charlton, S. J., Munson, S. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011651107 · Cited by 101
Self-citationProtein kinase C inhibits caveolae-mediated endocytosis of TRPV5
Cha, S., Wu, T., & Huang, C.-L. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00007.2008 · Cited by 101
Cea-del Rio, C. A., Lawrence, J. J., Tricoire, L., Erdelyi, F., Szabo, G., & McBain, C. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5040-09.2010 · Cited by 99
“Animals. mAChR knock-out (KO) mice (Wess et al., 2007) were received from Taconic with permission of the owner Dr. Jurgen Wess [National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health].”
MethodLebois, E. P., Bridges, T. M., Lewis, L. M., Dawson, E. S., Kane, A. S., Xiang, Z., Jadhav, S. B., Yin, H., Kennedy, J. P., Meiler, J., et al. (2009) · ACS Chemical Neuroscience · doi:10.1021/cn900003h · Cited by 106
The ART of Loss: Aβ Imaging in the Evaluation of Alzheimer’s Disease and other Dementias
Villemagne, V. L., Fodero‐Tavoletti, M. T., Pike, K. E., Cappai, R., Masters, C. L., & Rowe, C. C. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8019-y · Cited by 118
Lack of Specificity of Commercially Available Antisera: Better Specifications Needed
Pradidarcheep, W., Labruyère, W. T., Dabhoiwala, N. F., & Lamers, W. H. (2008) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2008.952101 · Cited by 96
Amici, M. D., Dallanoce, C., Holzgrabe, U., Tränkle, C., & Mohr, K. (2009) · Medicinal Research Reviews · doi:10.1002/med.20166 · Cited by 106
Targeting glutamate synapses in schizophrenia
Field, J. R., Walker, A. G., & Conn, P. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.08.004 · Cited by 106
Liu, Q., Zheng, Y., Korde, A. S., Yadav, V., Rathore, R., Wess, J., & Wang, Y.-X. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813307106 · Cited by 96
Self-citationKistemaker, L. E. M., Oenema, T. A., Meurs, H., & Gosens, R. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.02.021 · Cited by 96
Guzman, M. S., De Jaeger, X., Raulic, S., Souza, I. A., Li, A. X., Schmid, S., Menon, R. S., Gainetdinov, R. R., Caron, M. G., Bartha, R., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001194 · Cited by 95
Intestinal Epithelial Wnt Signaling Mediates Acetylcholine-Triggered Host Defense against Infection
Labed, S. A., Wani, K. A., Jagadeesan, S., Hakkim, A., Najibi, M., & Irazoqui, J. E. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.017 · Cited by 94
Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: Role of M1 muscarinic receptors
Maltese, M., Martella, G., Madeo, G., Fagiolo, I., Tassone, A., Ponterio, G., Sciamanna, G., Burbaud, P., Conn, P. J., Bonsi, P., et al. (2014) · Movement Disorders · doi:10.1002/mds.26009 · Cited by 101
Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases
Cabral-Marques, O., & Riemekasten, G. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.134 · Cited by 105
Acetylcholine receptors: Key players in cancer development
Chen, J., Cheuk, I., Shin, V. Y., & Kwong, A. (2019) · Surgical Oncology · doi:10.1016/j.suronc.2019.09.003 · Cited by 101
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Conflitti, P., Lyman, E. R., Sansom, M. S. P., Hildebrand, P. W., Gutiérrez‐de‐Terán, H., Carloni, P., Ansell, T. B., Yuan, S., Barth, P., Robinson, A. S., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01083-3 · Cited by 119
Bonsi, P., Martella, G., Cuomo, D., Platania, P., Sciamanna, G., Bernardi, G., Wess, J., & Pisani, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1678-08.2008 · Cited by 91
Self-citationAbdAlla, S., Lother, H., el Missiry, A., Langer, A., Sergeev, P., el Faramawy, Y., & Quitterer, U. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807746200 · Cited by 89
Classics in Chemical Neuroscience: Donepezil
Brewster, J. T., Dell’Acqua, S., Thach, D. Q., & Sessler, J. L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00517 · Cited by 98
Conformational Complexity and Dynamics in a Muscarinic Receptor Revealed by NMR Spectroscopy
Xu, J., Hu, Y., Kaindl, J. M., Risel, P., Hübner, H., Maeda, S., Niu, X., Li, H., Gmeiner, P., Jin, C., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.04.028 · Cited by 91
Alzheimer's disease and age-related memory decline (preclinical)
Terry, A. V., Callahan, P. M., Hall, B., & Webster, S. J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.002 · Cited by 86
Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease
Ztaou, S., & Amalric, M. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.02.019 · Cited by 93
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss
Bradley, S. J., Bourgognon, J.-M., Sanger, H. E., Verity, N., Mogg, A. J., White, D. J., Butcher, A. J., Moreno, J. A., Molloy, C., Macedo-Hatch, T., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87526 · Cited by 81
Self-citationSynthesis, trafficking, and localization of muscarinic acetylcholine receptors
Nathanson, N. M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.04.006 · Cited by 90
Santini, E., Sepulveda-Orengo, M. T., & Porter, J. T. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.52 · Cited by 87
Metadata
- Authors
- Wess, J., Eglen, R. M., & Gautam, D.
- Affiliations
- National Institutes of Health (US)
- PerkinElmer (United States) (US)
- Corresponding author
- Wess, Jürgen
- ORCID
- Wess, Jürgen
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-09
- Volume
- 6
- Issue
- 9
- Pages
- 721-733
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1999774383
- Cited by
- 637
- References
- 134
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 29 · 2023: 33 · 2022: 21 · 2021: 25 · 2020: 23 · 2019: 29 · 2018: 36 · 2017: 32 · 2016: 38 · 2015: 26 · 2014: 45 · 2013: 40 · 2012: 43
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- muscarinic receptors, knockout mice, Alzheimer's disease, schizophrenia, pain, obesity, diabetes mellitus, receptor function
- MeSH terms
- Animals, Disease Models, Animal, Ligands, Receptors, Muscarinic, Drug Design, Mice, Knockout, Muscarinic Agonists, Muscarinic Antagonists, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.